Viromed Medical AG (XTER:VME) Net Margin %: 17.40% (As of Dec. 2025)


XTER:VME Viromed Medical AG XTER:VME
15 GF Score
Price €7.20
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG Net Margin %?

Viromed Medical AG XTER:VME -2.04% 15 Net Margin % is 17.40% as of Dec. 2025. GuruFocus rates XTER:VME with a GF Score™ of 15/100. The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Viromed Medical AG ranks better than 77.6% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Viromed Medical AG's Net Income for the six months ended in Dec. 2025 was €0.89 Mil. Viromed Medical AG's Revenue for the six months ended in Dec. 2025 was €5.09 Mil. Therefore, Viromed Medical AG's net margin for the quarter that ended in Dec. 2025 was 17.40%.

The historical rank and industry rank for Viromed Medical AG's Net Margin % or its related term are showing as below:

XTER:VME' s Net Margin % Range Over the Past 10 Years
Min: -274.93   Med: -131.52   Max: 11.89
Current: 11.89

XTER:VME's Net Margin % is ranked better than
77.6% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 2.09 vs XTER:VME: 11.89

Viromed Medical AG  (XTER:VME) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Viromed Medical AG Net Margin % Related Terms

Viromed Medical AG Net Margin % Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Net Margin % Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00 -274.93 11.89

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -260.80 0.00 17.40

XTER:VME vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, Viromed Medical AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viromed Medical AG Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Viromed Medical AG's Net Margin % falls into.


XTER:VME
15GF Score
Viromed Medical AG XTER:VME
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Viromed Medical AG's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.605/5.087
=11.89 %

Viromed Medical AG's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.885/5.087
=17.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 17.40% mean?
Viromed Medical AG (XTER:VME) has a Net Margin % of 17.40% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Viromed Medical AG and its competitors. According to the industry distribution chart, Viromed Medical AG ranks #183 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 22.4%.
Is Viromed Medical AG's Net Margin % too high?
Viromed Medical AG's current Net Margin % is 17.40%. The Medical Devices & Instruments industry median Net Margin % is 2.09. Viromed Medical AG's value of 17.40% is 732.5% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #183 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viromed Medical AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #183 out of 817 companies for Net Margin %. This places Viromed Medical AG in the top 22% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Viromed Medical AG's value of 17.40% is 732.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current Net Margin % of 17.40% is 732.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current Net Margin % is 17.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Net Margin % of 17.40%. The current Net Margin % is 17.40% and 732.5% above the Medical Devices & Instruments industry median of 2.09. Viromed Medical AG's overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Net Margin % is 17.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
15GF Score

Get the complete analysis for XTER:VME

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.20
Price